Stephen Lamond

Stephen LaMond, PharmD, MBA, serves as the Interim CEO and COO at Peak Bio Inc., overseeing board activities, investor relations, and operational management of a clinical and regulatory organization focused on innovative oncology technologies. Additionally, Stephen is a member of the Board of Directors at Peak Bio, contributing to corporate strategy and governance. Stephen holds the position of Vice President of Corporate and Business Development at Hannol Ventures, targeting investment opportunities in oncology and immunology. With extensive experience in business development across various life sciences companies, Stephen has held leadership roles at organizations such as Kyperion, pH Pharma, Corium International, and ZOLL Circulation. Educational qualifications include a PharmD from the University of Michigan College of Pharmacy and an MBA from the University of Michigan's Stephen M. Ross School of Business, supplemented by executive management courses at Columbia and Stanford.